The Medicine Maker | The Medicine Maker

The Science of Listening

June 15, 2026

Why patient voices must shape rare disease innovation

4 min read

Cell & Gene

Tissue-Resident NK Cells Slow Solid Tumor Growth in Mice

The study points to a possible off-the-shelf cell therapy for solid tumors

Cell & Gene

Stem Cells More Cost-Effective than Gene Therapy for Sickle Cell Disease

Researchers found gene therapy produced the highest modeled health benefit, but haploidentical stem cell transplantation offered better value at current prices

Biopharma

Parabilis Sets Biotech IPO Record

The clinical-stage cancer biotech raised $670 million in an upsized Nasdaq debut, with a further $75 million expected from a concurrent Regeneron private placement

Cell & Gene

The Scalability Challenge in MSC Therapies

John Yoshi Shyu on why mesenchymal stem cell programs stall – and how early manufacturing decisions can determine clinical and commercial success

Cell & Gene Small Molecules Biopharma Future of Pharma

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

Our celebration of the most inspirational and influential leaders in medicine.

Find out more

Christine Allen

Professor, University of Toronto; Co-founder and CEO, Intrepid Labs

View Profile

Hanns-Christian Mahler

CEO (Chief Enablement Officer) & Board Member, ten23 health

View Profile

FOYA: Celebrating Innovation in Pharma Facilities

We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.

Read the article

All the latest Medicine Maker articles.

Cell & Gene Development & Clinical Business & Trends

Roving Reporter Asks: What Emerging Approaches Could Define the Next Wave of Advanced Therapies?

June 11, 2026

IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore the emerging modalities and technologies that could shape the next era of cell and gene therapy

Regulation & Standards Future of Pharma

AI in Drug Development: Moving Beyond Early Use Cases

June 10, 2026

As new rules take hold, what does “good AI practice” look like in drug development?

6 min read

Biopharma Research News Industry News

This Week’s Biopharma News: Big Moves in Bispecifics

June 9, 2026

Akeso’s PD-1/VEGF bispecific beats PD-1 plus chemo in lung cancer, Amgen wins EC approval for its DLL3-targeted T-cell engager, and Aragen scales Renaissance’s Fast Track anti-GD2 antibody

4 min read

Cell & Gene Interviews Business & Trends

Building the Cell Therapy Ecosystem

June 8, 2026

Antoinette Gawin discusses leadership, innovation in blood and cell therapy, and the global systems shaping access to advanced medicine

10 min read

Cell & Gene Industry News Research News

This Week’s CGT News: Promising Data for In Vivo CAR T

June 8, 2026

Legend and Kelonia reveal 100 percent response rates in phase 1 trials, dual CAR T opens doors for kidney transplant patients, and iPDSC therapy beefs up failing hearts

5 min read

Biopharma Development & Clinical Outsourcing Business & Trends

Earendil: A Blueprint for a Multipolar Life Sciences Era

June 5, 2026

The $787M financing points to a new global architecture in biotech

5 min read

Cell & Gene Business & Trends

Roving Reporter Asks: How Is Shifting Investment Reshaping Advanced Therapies?

June 4, 2026

IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore how a tougher funding environment is sharpening focus on scalability, cost-efficiency, partnerships, and commercialization in advanced therapies

1 min read

Biopharma Interviews Drug Discovery Development & Clinical

HTC-19 Profile: What’s Cooking in the mRNA Lab?

June 3, 2026

Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking

3 min read

Small Molecules Small Molecules Development & Clinical Interviews

The Case for Simulating Pregnancy

June 2, 2026

Why drug trials exclude pregnant women – and how simulation could change that

7 min read

Biopharma Biopharma Industry News Research News Sponsored

This Week’s Biopharma News: New Approvals, Appeals, and AI

June 2, 2026

Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic

6 min read

Top Stories